Peter R. Strack

3.6k citations

34 papers · 2.8k · 2 hit papers · h-index 20

Impact in

Cancer Research top 5%
Virology top 5%

Papers in

Molecular Biology 24
- Developmental Biology and Gene Regulation 7
- Ubiquitin and proteasome pathways 4
- DNA Repair Mechanisms 2
Oncology 12
- Cancer-related Molecular Pathways 6

Co-authors: Peggy Beer‐Romero (2 shared papers)Stephen J. Elledge (1 shared paper)J. Wade Harper (1 shared paper)Chia‐Yu Chu (1 shared paper)Jeffrey Winston (1 shared paper)A. Thomas Look (4 shared papers)Jennifer O’Neil (4 shared papers)Giulio Draetta (4 shared papers)
Journals: Cancer Research (9 papers)Clinical Cancer Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Advances in experimental medicine and biology (2 papers)Molecular Cancer Therapeutics (2 papers)
Partner nations: United States United Kingdom Brazil

In The Last Decade

Peter R. Strack

34 papers receiving 2.8k citations

Peter R. Strack's Hit Papers

align trajectories log scale

FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors 2007 · 523 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 The Journal of Experimental Medicine
1999 Genes & Development

Peers

Countries citing papers authored by Peter R. Strack

Since Specialization

Citations

This map shows the geographic impact of Peter R. Strack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Strack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Strack more than expected).

Fields of papers citing papers by Peter R. Strack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Strack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Strack. The network helps show where Peter R. Strack may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter R. Strack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter R. Strack Line = papers co-authored together Peter R. Strack links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The SCFbeta -TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in Ikappa Balpha and beta -catenin and stimulates Ikappa Balpha ubiquitination in vitro Genes & Development ·Jeffrey Winston, Peter R. Strack, Peggy Beer‐Romero, Chia‐Yu Chu, Stephen J. Elledge, J. Wade Harper Hit paper breakdown →	1999	806
2	FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors The Journal of Experimental Medicine ·Jennifer O’Neil, Jonathan Grim, Peter R. Strack, Sudhir Rao, Deanne Tibbitts, Christopher Winter, James C.H. Hardwick, Markus Welcker, Jules P.P. Meijerink, Rob Pieters, Giulio Draetta, Rosalie C. Sears, Bruce E. Clurman, A. Thomas Look Hit paper breakdown →	2007	523
3	Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2. Proceedings of the National Academy of Sciences ·Peter R. Strack, Michelle West Frey, Carmelo J. Rizzo, Beverly C. Cordova, Henry J. George, Robin Meade, S. P. HO, John M. Corman, R.J. Tritch, Bruce D. Korant	1996	167
4	Oxygen Concentration Determines the Biological Effects of NOTCH-1 Signaling in Adenocarcinoma of the Lung Cancer Research ·Yuanbin Chen, Melissa A. De Marco, Irene Graziani, Adi F. Gazdar, Peter R. Strack, Lucio Miele, Maurizio Bocchetta	2007	123
5	Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. PubMed ·Peter Grudzien, Shelly S. Lo, Kathy S. Albain, Patricia A. Robinson, Prabha Rajan, Peter R. Strack, Todd E. Golde, Lucio Miele, Kimberly E. Foreman	2010	119
6	Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells Cancer Research ·Sudhir Rao, Jennifer O’Neil, Cole D. Liberator, James S. Hardwick, Xudong Dai, Theresa Zhang, Edyta Tyminski, Jing Yuan, Nancy E. Kohl, Victoria M. Richon, Lex H.T. Van der Ploeg, Pamela M. Carroll, Giulio Draetta, A. Thomas Look, Peter R. Strack, Christopher Winter	2009	115
7	Apoptosis in T Cell Acute Lymphoblastic Leukemia Cells after Cell Cycle Arrest Induced by Pharmacological Inhibition of Notch Signaling Chemistry & Biology ·Huw D. Lewis, Matthew Leveridge, Peter R. Strack, Christine Haldon, Jennifer O’Neil, Hellen Kim, Andrew Madin, Joanne C. Hannam, A. Thomas Look, Nancy E. Kohl, Giulio Draetta, Timothy Harrison, Julie Kerby, Mark S. Shearman, Dirk Beher	2007	111
8	Opposite Effects of Notch-1 and Notch-2 on Mesothelioma Cell Survival under Hypoxia Are Exerted through the Akt Pathway Cancer Research ·Irene Graziani, Sandra Eliasz, Melissa A. De Marco, Yuanbin Chen, Harvey I. Pass, Richard M. De May, Peter R. Strack, Lucio Miele, Maurizio Bocchetta	2008	95
9	Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors Proceedings of the National Academy of Sciences ·Zhihong Lai, Tao Yang, Young B. Kim, Thais M. Sielecki, Melody Diamond, Peter R. Strack, Mark Rolfe, Maureen Caligiuri, Pamela A. Benfield, Kurt R. Auger, Robert A. Copeland	2002	86
10	Inhibition of Notch Signaling Blocks Growth of Glioblastoma Cell Lines and Tumor Neurospheres Genes & Cancer ·Y-H. Chen, Santosh Kesari, Cliona M. Rooney, Peter R. Strack, Huangxuan Shen, Lizi Wu, J D Griffin	2010	83
11	Downregulation of Notch Pathway by a γ-Secretase Inhibitor Attenuates AKT/Mammalian Target of Rapamycin Signaling and Glucose Uptake in an ERBB2 Transgenic Breast Cancer Model Cancer Research ·Clay L. Efferson, Christopher T. Winkelmann, Christopher Ware, Timothy M. Sullivan, Saverio Giampaoli, Jennifer Tammam, Shailendra B. Patel, Giuseppe Mesiti, John F. Reilly, Raymond E. Gibson, Carolyn A. Buser, Timothy J. Yeatman, Domenico Coppola, Christopher Winter, Edwin Clark, Giulio Draetta, Peter R. Strack, Pradip K. Majumder	2010	76
12	Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models Molecular Cancer Therapeutics ·Chaoxin Hu, Tikva Dadon, Venugopal Chenna, Shinichi Yabuuchi, Rajat Bannerji, Robert Booher, Peter R. Strack, Nilofer S. Azad, Barry D. Nelkin, Anirban Maitra	2015	60
13	Valosin-Containing Protein Phosphorylation at Ser784 in Response to DNA Damage Cancer Research ·Mark Livingstone, Hong Ruan, Jessica Weiner, Karl R. Clauser, Peter R. Strack, Shengfang Jin, Amy J. Williams, Heidi Greulich, James M. Gardner, Monica Venere, Tamara A. Mochan, Richard A. DiTullio, Katarina Moravcevic, Vassilis G. Gorgoulis, Anne L. Burkhardt, Thanos D. Halazonetis	2005	56
14	Crosstalk between PKCα and Notch-4 in endocrine-resistant breast cancer cells Oncogenesis ·Jieun Yun, Antonio Pannuti, Ignacio Espinoza, He Zhu, Chindo Hicks, Xulong Zhu, M. W. Caskey, Paola Rizzo, Gwendolyn D'Souza, Kandis V. Backus, Mitchell F. Denning, John S. Coon, Mu Sun, Emery H. Bresnick, Clodia Osipo, Jing Wu, Peter R. Strack, Debra A. Tonetti, Lucio Miele	2013	56
15	Control of Cell Growth and Survival by Enzymes of the Fatty Acid Synthesis Pathway in HCT-116 Colon Cancer Cells Clinical Cancer Research ·Yanai Zhan, Nicole Ginanni, Michael R. Tota, Margaret Wu, Nathan Bays, Victoria M. Richon, Nancy E. Kohl, Eric Bachman, Peter R. Strack, Stefan Krauß	2008	53
16	Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia Blood ·Takaomi Sanda, Xiaoyu Li, Alejandro Gutiérrez, Yebin Ahn, Donna Neuberg, Jennifer O’Neil, Peter R. Strack, Christopher Winter, Stuart S. Winter, Richard A. Larson, Harald von Boehmer, A. Thomas Look	2009	52
17	Activation of the Multicatalytic Endopeptidase by Oxidants. Effects on Enzyme Structure Biochemistry ·Peter R. Strack, Lloyd Waxman, Julie M. Fagan	1996	50
18	3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors Bioorganic & Medicinal Chemistry Letters ·Alexey Rivkin, Yoona R. Kim, Mark T. Goulet, Nathan Bays, Armetta Hill, Ilona Kariv, Stefan Krauß, Nicole Ginanni, Peter R. Strack, Nancy E. Kohl, (unknown), Jeffrey P. Varnerin, Paul N. Goudreau, Amy Chang, Michael R. Tota, Benito Muñoz	2006	42
19	SCFβ-TRCP and phosphorylation dependent ubiquitination of IκBα catalyzed by Ubc3 and Ubc4 Oncogene ·Peter R. Strack, Maureen Caligiuri, Marc R. Pelletier, M Boisclair, Anne M. Theodoras, Peggy Beer‐Romero, Susan Glass, Tom Parsons, Robert A. Copeland, K R Auger, Pamela A. Benfield, Leonardo Brizuela, Mark Rolfe	2000	33
20	Level of phosphohistone H3 among various types of human cancers BMJ Open ·Amy Sun, Wei Zhou, Jared Lunceford, Peter R. Strack, Lisa M. Dauffenbach, Christopher A. Kerfoot	2012	24

About Peter R. Strack

Peter R. Strack is a scholar working on Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 34 papers that have together received 2.8k indexed citations. Recurring topics across this work include Developmental Biology and Gene Regulation (7 papers), Cancer-related Molecular Pathways (6 papers), Ubiquitin and proteasome pathways (4 papers), Advanced Breast Cancer Therapies (4 papers), Cancer, Lipids, and Metabolism (3 papers), HIV/AIDS drug development and treatment (3 papers), HIV Research and Treatment (3 papers) and DNA Repair Mechanisms (2 papers). The work is most often cited by research in Cancer Research (481 citations), Virology (134 citations), Oncology (745 citations), Molecular Biology (2.0k citations) and Hematology (198 citations). Peter R. Strack has collaborated with scholars based in United States, United Kingdom and Brazil. Frequent co-authors include Peggy Beer‐Romero, Stephen J. Elledge, J. Wade Harper, Chia‐Yu Chu, Jeffrey Winston, A. Thomas Look, Jennifer O’Neil, Giulio Draetta, Christopher Winter and Sudhir Rao. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Proceedings of the National Academy of Sciences, Advances in experimental medicine and biology and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Peter R. Strack

Impact in

Papers in i

In The Last Decade

Peter R. Strack

Peter R. Strack's Hit Papers

Peers

Countries citing papers authored by Peter R. Strack

Fields of papers citing papers by Peter R. Strack

All Works

About Peter R. Strack

Explore authors with similar magnitude of impact

Papers in